LSTM’s vector-borne disease research
- Video
4 December 2025
Around 17% of infectious diseases are transmitted by insects, including malaria, which still kills over half a million children in Africa every year, and dengue, which puts around half of the world’s population at risk.
At LSTM, we’re bringing together scientists, clinicians and global partners to change that, developing new tools, treatments and strategies to reduce the burden of vector-borne disease.
[00:00:00] 17% of the wold infectious diseases are transmitted by insects. This includes diseases like malaria, which still kill over half a million children in Africa each year. And Dengue, which infects hundreds of millions of people with half of the globe at risk of this mosquito-borne disease.
Here at LSTM, we are working across disciplines to provide innovative and effective solutions to prevent the transmission of these diseases and to provide effective treatments. This is enabled by our world-class infrastructure. Including insectaries and a high containment automated facility that enables us to rapidly screen new drugs and new vaccines.
We also have clinical expertise in facilities that enable us to test these new treatments under controlled settings before moving into full field trials this is enabled by our strong partnerships with industry and with [00:01:00] partners across the globe, particularly those in regions where these diseases are most prevalent.